These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9463877)

  • 1. Development of high-activity 252Cf sources for neutron brachytherapy.
    Martin RC; Laxson RR; Miller JH; Wierzbicki JG; Rivard MJ; Marsh DL
    Appl Radiat Isot; 1997; 48(10-12):1567-70. PubMed ID: 9463877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol.
    Rivard MJ; Wierzbicki JG; Van den Heuvel F; Martin RC; McMahon RR
    Med Phys; 1999 Jan; 26(1):87-96. PubMed ID: 9949403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production, distribution and applications of californium-252 neutron sources.
    Martin RC; Knauer JB; Balo PA
    Appl Radiat Isot; 2000; 53(4-5):785-92. PubMed ID: 11003521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The CT-stereotaxic neutron brachytherapy of brain tumors with californium sources on the ANET-B apparatus].
    Melikian AG; Liass FM; Shkol'nik FG; Chekhonadskiĭ VN; Elisiutin GP; Golanov AV; Kachkov IA; Borodkin SM; Lobanov SA; Spasokukotskaia ON
    Zh Vopr Neirokhir Im N N Burdenko; 1992; (2-3):15-21. PubMed ID: 1326193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental determination of the thermal neutron flux around two different types of high intensity 252Cf sources.
    Schmidt B; Maughan RL; Yudelev M; Kota C; Wanwilairat S
    Med Phys; 1999 Jan; 26(1):83-6. PubMed ID: 9949402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
    Rivard MJ
    Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote afterloading for neutron brachytherapy using californium-252.
    Tacev T; Grigorov G; Papírek T; Kolarík V
    Strahlenther Onkol; 2003 Feb; 179(2):113-7. PubMed ID: 12590322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements and calculations of thermal neutron fluence rate and neutron energy spectra resulting from moderation of 252Cf fast neutrons: applications for neutron capture therapy.
    Rivard MJ
    Med Phys; 2000 Aug; 27(8):1761-9. PubMed ID: 10984222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interstitial neutron therapy using flexible 252Cf sources].
    Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
    Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron capture.
    Wierzbicki JG; Maruyama Y; Porter AT
    Med Phys; 1994 Jun; 21(6):787-90. PubMed ID: 7935215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutron dosimetry for a general 252Cf brachytherapy source.
    Rivard MJ
    Med Phys; 2000 Dec; 27(12):2803-15. PubMed ID: 11190964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Californium-252 interstitial implants in carcinoma of the tongue.
    Vtyurin BM; Ivanov VN; Medvedev VS; Galantseva GF; Abdulkadyrov SA; Ivanova LF; Petrovskaya GA; Plichko VI
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):441-9. PubMed ID: 3972658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron capture enhancement of 252Cf brachytherapy.
    Beach JL; Schroy CB; Ashtari M; Harris MR; Maruyama Y
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1421-7. PubMed ID: 2370192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry of 252Cf sources for neutron radiotherapy with and without augmentation by boron neutron capture therapy.
    Yanch JC; Zamenhof RG
    Radiat Res; 1992 Sep; 131(3):249-56. PubMed ID: 1438684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of brachytherapy with californium-252 neutrons versus cesium-137 photons for eradication of bulky localized cervical cancer: single-institution study.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson E; Gallion H; Higgins R; Powell D; Turner C; Kryscio R
    J Natl Cancer Inst; 1988 Jun; 80(7):501-6. PubMed ID: 3367388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the expected costs of high dose rate brachytherapy using 252Cf versus 192Ir.
    Rivard MJ; Kirk BL; Stapleford LJ; Wazer DE
    Appl Radiat Isot; 2004 Dec; 61(6):1211-6. PubMed ID: 15388112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contact neutron therapy of tumors with 252Cf irradiation].
    Vtiurin BM
    Med Radiol (Mosk); 1987 Sep; 32(9):62-7. PubMed ID: 3657457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
    Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
    Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.
    Patchell RA; Yaes RJ; Beach L; Kryscio RJ; Davis DG; Tibbs PA; Young B
    Br J Radiol; 1997 Nov; 70(839):1162-8. PubMed ID: 9536908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.